BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in MIRM — Mirum Pharmaceuticals, Inc.
CIK 1520354
Paris, I0
Position in MIRM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,146,097
+$4,607,107 QoQ
Shares Held
248,963
-6.3% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#61
of 327 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MIRM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. MIRM ranks #22 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in MIRM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,146,097 | 248,963 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $24,538,990 | 265,631 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $20,318,439 | 257,228 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $13,943 | 274 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||